16.06.2017

Finland excels in biomedical engineering and medical physics

A joint conference of the European Medical and Biological Engineering Conference (EMBEC) and the Nordic-Baltic Conference on Biomedical Engineering and Medical Physics (NBC) was held in Tampere, Finland on the 11-15 June. The event is one of a kind and the largest event in its area in Europe with over 600 participants from 50 countries. Finnish governmental organization, Finpro was at the event introducing it’s invest in Finland services as well as Finland Health program. Finpro’s Enterprise Europe Network arranged a networking event for international players.


One of the key note speakers at the event was Nobel prize winner in chemistry, Dr. Stefan W. Hell. He pioneered the physical concepts for breaking the diffraction barrier in a microscope using conventional lenses. His innovations include development of STED microscopy and related concepts and discovery of the on-off switching of (fluorescence) signal as key mechanism for overcoming the diffraction resolution limit.


EMBEC’17 & NBC’17 was a platform for engineers, physicists, biologists, and clinical experts to enhance knowledge and scientific achievements. The exhibition area provided possibilities for businesses and academia to meet.  Finnish start-ups were recognized with a special showcase area. Also well-established and international companies were introducing their innovations. See the list here: http://embec2017.org/confirmed-sponsors-and-exhibitors/


- We aim to also highlight new emerging fields, such as tissue engineering, bioinformatics, biosensing, neurotechnology, additive manufacturing technologies for medicine and biology, and bioimaging, to name a few. Moreover, we will emphasize the role of education, translational research, and commercialization says Jari Hyttinen, Chair of the EMBEC’17 & NBC’17 Conference


The main organizer of the event was BioMediTech that conducts world-class basic and translational research in biomedicine and medical technology. Its research activities cover for example, biomaterials, stem cells, cancer, immunology, biosensors, imaging, and computational methods, with a common aim of developing personalized medicine via new diagnostic and treatment methods.

 

Finland is identified as a health technology forerunner and excels in biomedical engineering

Finnish health technology in globally renowned and Finland is one of the only seven countries in the World that export more health technology that it imports. The annual exports of Finnish health technologies were than 2 billion euro in 2016 with a compound annual growth rate (CAGR) of 9.7% between 2011-16 (Healthtech Finland).

 

The event is one of a kind and the largest event in its area in Europe with over 600 participants from 50 countries.



Many leading health technology companies have identified Finland as a health technology forerunner and for this reason have established R&D sites and Centers of Excellence in Finland – among these globally leading companies are GE healthcare, Thermo Fisher Scientific, Danaher, PerkinElmer and Bayer.


A fresh example of a newcomer in Finland is from last week. An American company Novasano announced its expansion to Finland. Novasano develops security solutions for consumer devices and patient care. It selected Finland for its product development environment because Finnish expertise is world-class, for example in terms of data privacy management, cyber security threat prevention, reliable infrastructure and identity management. Novasano also held a side event about cyber security at EMBEC´17 conference. Read the press release.

 

Text by Katri Raevuori and Maria Arruda